GLAUKOS CORP (GKOS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:GKOS - US3773221029 - Common Stock
119.98 USD
-5.92 (-4.7%)
119.98 USD
0 (0%)
Taking everything into account, GKOS scores 4 out of 10 in our fundamental rating. GKOS was compared to 186 industry peers in the Health Care Equipment & Supplies industry. GKOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GKOS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
- GKOS had negative earnings in the past year.
- GKOS had a negative operating cash flow in the past year.
- In the past 5 years GKOS always reported negative net income.
- GKOS had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- GKOS has a Return On Assets of -8.77%. This is in the better half of the industry: GKOS outperforms 63.44% of its industry peers.
- GKOS has a better Return On Equity (-11.39%) than 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.77% | ||
| ROE | -11.39% | ||
| ROIC | N/A |
ROA(3y)-13.08%
ROA(5y)-11.18%
ROE(3y)-22.32%
ROE(5y)-18.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of GKOS (76.87%) is better than 88.17% of its industry peers.
- GKOS's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for GKOS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.87% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-2.05%
2. Health
2.1 Basic Checks
- GKOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- GKOS has more shares outstanding than it did 1 year ago.
- GKOS has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, GKOS has an improved debt to assets ratio.
2.2 Solvency
- GKOS has an Altman-Z score of 18.37. This indicates that GKOS is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 18.37, GKOS belongs to the top of the industry, outperforming 94.09% of the companies in the same industry.
- A Debt/Equity ratio of 0.09 indicates that GKOS is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.09, GKOS is doing good in the industry, outperforming 65.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 18.37 |
ROIC/WACCN/A
WACC9.9%
2.3 Liquidity
- GKOS has a Current Ratio of 5.20. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 5.20, GKOS belongs to the best of the industry, outperforming 80.11% of the companies in the same industry.
- GKOS has a Quick Ratio of 4.47. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of GKOS (4.47) is better than 80.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.2 | ||
| Quick Ratio | 4.47 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 52.11% over the past year.
- Looking at the last year, GKOS shows a very strong growth in Revenue. The Revenue has grown by 30.38%.
- The Revenue has been growing by 10.10% on average over the past years. This is quite good.
EPS 1Y (TTM)52.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y9.26%
Revenue growth 5Y10.1%
Sales Q2Q%38.14%
3.2 Future
- Based on estimates for the next years, GKOS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.44% on average per year.
- Based on estimates for the next years, GKOS will show a very strong growth in Revenue. The Revenue will grow by 27.86% on average per year.
EPS Next Y55.28%
EPS Next 2Y35.02%
EPS Next 3Y32.68%
EPS Next 5Y27.44%
Revenue Next Year30.36%
Revenue Next 2Y27.15%
Revenue Next 3Y27.26%
Revenue Next 5Y27.86%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for GKOS. In the last year negative earnings were reported.
- Also next year GKOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- GKOS's earnings are expected to grow with 32.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.02%
EPS Next 3Y32.68%
5. Dividend
5.1 Amount
- GKOS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GLAUKOS CORP / GKOS FAQ
Can you provide the ChartMill fundamental rating for GLAUKOS CORP?
ChartMill assigns a fundamental rating of 4 / 10 to GKOS.
What is the valuation status for GKOS stock?
ChartMill assigns a valuation rating of 1 / 10 to GLAUKOS CORP (GKOS). This can be considered as Overvalued.
How profitable is GLAUKOS CORP (GKOS) stock?
GLAUKOS CORP (GKOS) has a profitability rating of 2 / 10.